BioLife Solutions Inc (BLFS)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 18,311 | 23,793 | 6,353 | 655 | — |
| Total stockholders’ equity | US$ in thousands | 337,663 | 364,188 | 478,047 | 204,429 | 43,321 |
| Debt-to-capital ratio | 0.05 | 0.06 | 0.01 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $18,311K ÷ ($18,311K + $337,663K)
= 0.05
The debt-to-capital ratio of BioLife Solutions Inc has exhibited an increasing trend over the past five years, from 0.00 in both 2019 and 2020 to 0.01 in 2021, further rising to 0.06 in 2022, and then slightly decreasing to 0.05 by the end of 2023. This indicates that the company's reliance on debt financing relative to its total capital has been on the rise, with a notable spike in 2022. While the decrease in 2023 suggests a slight improvement in the ratio, it still signifies a moderate level of debt utilization in financing the company's operations and investments. Investors and stakeholders may monitor this trend to assess BioLife Solutions Inc's financial leverage and risk management strategies.
Peer comparison
Dec 31, 2023